CLINICAL_TRIALS
trial_result
· 2022-08-22
Clinical Trial Update: 68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO) [Phase 3]
Summary
Phase 3 clinical trial evaluating 68Ga citrate PET/MRI for fever of unknown origin was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Carina Mari Aparici | Conditions: Fever of Unknown Origin | Phase 3 | Status: WITHDRAWN